Do you want to read an article? Please log in or register.
Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations
Pulmonary Fibrosis
RECOMMENDED
Related content
Pulmonary Fibrosis
Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012-2020
Respir Med
Eid E, Payet C, Fernandez V, Belhassen M, Bessou A, Durieu I, Reynaud Q, Viprey M, French Cystic Fibrosis Centers Network, Cinthia R, Françoise T, Marie-Laure D, Bénédicte RT, Stéphanie B, Julie M, Murie L, Sylvie M, Ralph E, Frédéric H, Manuela S, Laurent M, Rébecca H, Catherine L, Camille A, Nathalie WD, Jane L, Philippe R, Jean-Christophe D, Martine RG, Raphaël C, Aurélie T, Anne G, Isabelle DB, Tiphaine B, Sylvie L, Pierre-Régis B, Isabelle S, Véronique H, Harriet C, Katia BK, Chantal B, Eric D, Sophie R, Christophe M, Nathalie A, Caroline P, Benjamin RP, Laurence W, Dominique G, Léa R, Marlène ME, Julie M, Laure C, Baptiste A, Gabsi Asma
doi: 10.1016/j.rmed.2026.108857
Pulmonary Fibrosis
Provider Knowledge of 2013 Cystic Fibrosis Infection Prevention and Control Guidelines for Outpatient Care
Pediatr Pulmonol
Williams CL, Ansar M, Zhou JJ, Ceppe A, LiPuma JJ, Saiman L, Muhlebach MS
doi: 10.1002/ppul.71439
Interstitial Lung DiseaseFurther Publications
The importance of considering progression speed in systemic sclerosis-associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study
Respir Res
Roeser A, Brillet PY, Tran Ba S, Caux F, Dhote R, Nunes H, Uzunhan Y
doi: 10.1186/s12931-025-03375-7
Further Publications
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies
Lancet Respir Med
Burgel PR, Da Silva J, Girodon E, Durieu I, Reynaud-Gaubert M, Murris-Espin M, Chiron R, Grenet D, Ramel S, Mely L, Hamidfar R, Douvry B, Houdouin V, Audousset C, Macey J, Mittaine M, Weiss L, Cosson L, Danner-Boucher I, Reix P, Baravalle M, Burnet E, Sermet-Gaudelus I, Martin C, Paillasseur JL, French Cystic Fibrosis Reference Network study group
doi: 10.1016/S2213-2600(25)00190-0
RECOMMENDED
Pulmonary Fibrosis
Cystic fibrosis year in review 2025
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
T Pallenberg S, Zamarrón de Lucas E, Párniczky A, Lopes de Bragança R
doi: 10.1016/j.jcf.2026.02.010
RECOMMENDED
Pulmonary Fibrosis
Effectiveness of CFTR modulator therapy on risk of death for individuals with cystic fibrosis
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Kurgansky KE, Collaco JM, Ng DK, Lesko CR
doi: 10.1016/j.chest.2026.04.041
RECOMMENDED
Emphysema
Long-term Follow-up Results of Patients with Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Calis AG, Uzer F, Gurbuz AF, Ozbey G, Cilli A
doi: 10.1016/j.rmed.2026.108780
RECOMMENDED
Pulmonary Fibrosis
Impact of Elexacaftor-Tezacaftor-Ivacaftor on fungal colonisation in children and adolescents with cystic fibrosis
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Sitterlé E, Bonnel AS, Roussey-Bihouee T, Blondé A, Ribault M, Wizla N, Bresson C, Persat F, Maubon D, Leroy J, Hassani F, Benhala L, Mounier M, Znaidi S, Ferroni A, Bougnoux ME, Sermet-Gaudelus I, Mycologist and Modul-CF groups
doi: 10.1016/j.jcf.2026.02.012
RECOMMENDED
Pulmonary Fibrosis
The diagnostic challenge of pancreatic cysts in patients with cystic fibrosis: a case series and review of the literature
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Fleurent A, Miseur B, Weynand B, Topal H, Dupont L, van Malenstein H
doi: 10.1016/j.jcf.2026.02.007